Top Story

Insulin dose increase smaller with basal-bolus therapy vs. other regimens

May 24, 2017

Adults with type 2 diabetes assigned to basal-bolus therapy require a smaller increase in insulin dose after 1 year compared with adults assigned to long-acting insulin or biphasic insulin, according to findings published in the Journal of Diabetes Investigation.

Satoru Tsujii, MD, PhD, of the department of endocrinology at Tenri Hospital in Japan, and colleagues evaluated data from the Diabetes Distress and Care Registry on 757 adults (mean age, 65.7 years) with type 2 diabetes (mean HbA1c level, 7.8%; mean duration of insulin therapy, 11.3 years) who presented to Tenri Hospital to determine the association between four insulin regimens and increases in HbA1c and insulin dose.

Congressional Budget Office estimates $119 billion in savings over 10 years for House-passed AHCA

May 24, 2017
The Congressional Budget Office — a non-partisan scoring agency — and the staff of the Joint Committee on Taxation released its cost estimate for the…
In the Journals

Infections, chronic hypertension increase risk for stroke in women with preeclampsia

May 24, 2017
Chronic hypertension, infections, underlying prothrombotic conditions and coagulopathies increased risk for pregnancy-associated stroke in women with preeclampsia…
In the Journals Plus

CVD mortality linked to free T4, TSH levels

May 24, 2017
The risk for cardiovascular disease mortality is raised with increasing free thyroxine levels and lower thyroid-stimulating hormone levels, according to findings…

Prescription drug prices rose nearly 10% in 2016

May 24, 2017
The cost of prescription drugs increased by 8.77% last year, the fourth consecutive year drug prices have gone up, according to data from the Truveris National Drug…
More News Headlines »

Rapid Response from Austin: Expanding Options in Type 2 Diabetes Management

This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.

Approximately 150 million people worldwide have diabetes mellitus and this number is expected to double by 2025…
More »
Meeting News

VIDEO: DDW 2017 features a variety of research on new obesity therapies

May 9, 2017
More »
The Endocrine Society Annual Meeting

The Endocrine Society Annual Meeting


Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

This activity is supported by an educational grant from Regeneron.

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence…
More »
Current Issues
View the Current Issue